1. Bioptigen Completes Series A Round Funding Investment Closes at $1.3 Million

    Bioptigen Completes Series A Round Funding Investment Closes at $1.3 Million
    FOR IMMEDIATE RELEASE August 7, 2006 Contact: Winn Maddrey 704.905.2912 BIOPTIGEN COMPLETES SERIES A FUNDING ROUND Investment Closes at $1.3 Million DURHAM, N.C. – Bioptigen, an optical technology company developing proprietary advances in the field of optical coherence tomography (OCT), announces the closing of its Series A round of funding. The round closed at $1.3 million and investors included the Piedmont Angel Network, the Inception Micro-Angel Fund and qualified individuals. Bioptigen w
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned